Teleflex (TFX) Stock Research

Friday

Teleflex price target raised by $5 at Raymond James, here's why

Aug 7, 9:46 AM

Thursday

Teleflex raises 2026 adjusted EPS view 6.90-$7.20 from $6.25-$6.55

Aug 6, 7:12 AM

Teleflex reports Q2 adjusted EPS $1.76, consensus $1.28

Aug 6, 7:09 AM

Over a week ago

Teleflex price target raised by $12 at Needham, here's why

Jul 31, 7:44 AM

Teleflex announces FDA BLA approval of Ezplaz freeze dried plasma

Jul 29, 4:42 PM

FDA grants Teleflex unit license for Ezplaz Freeze Dried Plasma

Jul 29, 12:15 PM

Teleflex initiated with neutral view at UBS

Jul 28, 6:46 AM

Teleflex awarded national central venous access agreement with Premier

Jul 21, 8:49 AM

Teleflex price target raised by $5 at Mizuho, here's why

Jul 15, 7:27 AM

Teleflex initiated with bullish view at BMO Capital, here's why

Jul 8, 4:27 PM

Teleflex initiated with bullish view at BMO Capital

Jul 8, 4:21 PM

Teleflex begins enrollment in BIOMAG-III Study

Jun 23, 6:32 AM

Teleflex's Freesolve RMS shows long-term safety in four-year study

Jun 9, 6:35 AM

Cerebras initiated, Crocs upgraded: Wall Street's top analyst calls

+12

Jun 8, 10:08 AM

Teleflex just upgraded at Piper Sandler, here's why

Jun 8, 5:39 AM

Teleflex announces private offering of $500M of senior notes

Jun 1, 7:48 AM

Teleflex price target raised by $22 at Raymond James, here's why

May 8, 9:15 AM

Teleflex price target raised by $5 at Mizuho

May 8, 7:20 AM

Teleflex just upgraded at RBC Capital, here's why

May 8, 5:29 AM

Teleflex still sees 2026 adjusted EPS view $6.25-$6.55, consensus $6.72

May 7, 7:16 AM

Teleflex reports Q1 adjusted EPS $1.39, consensus $1.22

May 7, 7:15 AM

Teleflex names Jason Weidman as President and CEO

Apr 30, 7:17 AM

Closing Bell Movers: Capital One, Interactive Brokers slip after results

+14

Apr 21, 7:23 PM

CVC and GTCR considering Teleflex takeover, Bloomberg reports

Apr 21, 5:59 PM

Teleflex price target raised by $10 at RBC Capital, here's why

Apr 14, 7:26 AM

Specialized Product Portfolio: Teleflex excels in niche, high-margin medical device segments, reducing broad market competition.

Global Market Presence: Extensive international operations allow Teleflex to capture market share across diverse geographic regions.

Strong Intellectual Property: Proprietary technologies and patents protect Teleflex's innovative medical devices from imitation.

Regulatory Compliance Challenges: Teleflex operates in a highly regulated environment, and non-compliance or delays in product approvals could significantly impact operations and market access.

Product Liability and Recalls: As a medical device manufacturer, Teleflex faces risks of product defects, recalls, and associated litigation that could result in substantial financial and reputational damage.

Intense Market Competition: The medical device industry is highly competitive, leading to pricing pressure, rapid innovation by rivals, and potential loss of market share for Teleflex.

Charts